Towards harmonized regulations for bioanalysis: Moving forward!

Bioanalysis

Volumn 2, Issue 4, 2010, Pages 689-691

  Van Amsterdam, Peter ^a   Lausecker, Berthold ^b   Luedtke, Silke ^c   Timmerman, Philip ^d   Brudny Kloeppel, Margarete ^e  

^a Chemical Design and Synthesis Unit   (Netherlands)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^d Johnson and Johnson ^*  (United States)

^e BAYER PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; BIOANALYSIS; EDITORIAL; FOOD AND DRUG ADMINISTRATION; PRACTICE GUIDELINE; STANDARDIZATION; SYMPOSIUM; VALIDATION PROCESS; CHEMICAL ANALYSIS; HUMAN; METHODOLOGY; SOCIAL CONTROL; STANDARD;

CHEMISTRY TECHNIQUES, ANALYTICAL; GUIDELINES AS TOPIC; HUMANS; SOCIAL CONTROL, FORMAL;

EID: 79951747139     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.10.37     Document Type: Editorial

References (13)

1. Viswanathan CT, Bansal S, Booth B et al. Bioanalytical method validation and implementation: best practices for chromatographic and ligand binding assays. AAPS J. 9(1), E30-E38 (2007).
2. Fast D, Kelley M, Viswanathan C et al. Workshop report and follow-up-AAPS workshop on current topics in GLP bioanalysis: assay reproducibility for incurred samples - implications of crystal city recommendations. AAPS J. 11(2), 238-241 (2009).
3. Savoie N, Booth BP, Garofolo F et al. The 2nd Calibration and Validation Group Workshop on recent issues in good laboratory practice bioanalysis. Bioanalysis 1(1), 19-30 (2009).
4. Timmerman P, Luedtke S, van Amsterdam P, Brudny-Kloeppel M, Lausecker B. Incurred sample reproducibility: views and recommendations by the European Bioanalysis Forum. Bioanalysis 1(6), 1049-1056 (2009).
5. Savoie N, Garofolo F, van Amsterdam P et al. White Paper on recent issues in regulated bioanalysis from the 3rd calibration and validation group workshop. Bioanalysis 2(1), 53-68 (2010).
6. Lausecker B, van Amsterdam P, Brudny- Kloeppel M, Luedtke S, Timmerman P. European Bioanalysis Forum and the way forward towards harmonized regulations. Bioanalysis 1(5), 873-875 (2009).
7. Abbott R. The broadening scope of validation: towards best practices in the world of bioanalysis. Bioanalysis 2(4), 703-708 (2010).
8. Timmerman P, Lowes S, Fast DM, Garofolo F. Request for global harmonization of the guidance for bioanalytical method validation and sample analysis. Bioanalysis 2(4), 683 (2010).
9. Shah VP, Midha KK, Dighe S, McGilveray IJ, Skelly JP. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Pharm. Res. 9, 588-592 (1992).
10. Shah VP, Midha KK, Findlay JWA et al. Bioanalytical method validation - a revisit with a decade of progress. Pharm. Res. 17, 1551-1557 (2000). (Pubitemid 32217566)
11. European Medicines Agency concept paper/ recommendations on the need for a (CHMP) guideline on the validation of bioanalytical methods. EMA/CHMP/EWP/531305/2008 www.ema.europa.eu/pdfs/human/ ewp/53130508en.pdf
12. US FDA. Guidance for Industry: Bioanalytical Method Validation. Rockville, MD, USA: US Department of Health and Human Services, FDA, Center for Drug Evaluation and Research, 2001 www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM070107.pdf
13. European Medicines Agency draft guideline on validation of bioanalytical methods. EMA/CHMP/EWP/192217/2009 www.ema.europa.eu/pdfs/human/ ewp/19221709en.pdf